Catalent investors are sitting on a loss of 47 percent if they invested three years ago

CTLT Stock  USD 61.11  0.11  0.18%   
Slightly above 55% of Catalent's private investors are presently thinking to get in. The analysis of overall sentiment of trading Catalent stock suggests that some investors are interested at this time. Catalent's investing sentiment can be driven by a variety of factors including economic data, Catalent's earnings reports, geopolitical events, and overall market trends.
  
As an investor its worth striving to ensure your overall portfolio beats the market average. But its virtually certain...

Read at finance.yahoo.com
Yahoo News
  

Catalent Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Catalent can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Catalent Fundamental Analysis

We analyze Catalent's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Catalent using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Catalent based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Beta

Beta Comparative Analysis

Catalent is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.

Catalent Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Catalent stock to make a market-neutral strategy. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics with similar companies.

Peers

Catalent Related Equities

PASGPassage Bio   68.66   
0%
100.0%
LYELLyell Immunopharma   3.26   
0%
4.0%
CNTBConnect Biopharma   2.91   
0%
4.0%
DSGNDesign Therapeutics   0.50   
0%
1.0%
FOLDAmicus Therapeutics   0.20   
0%
1.0%
ORICOric Pharmaceuticals   0.70   
1.0%
0%
CRNXCrinetics Pharmaceuticals   0.81   
1.0%
0%
LGNDLigand Pharmaceuticals   0.88   
1.0%
0%
RVMDRevolution Medicines   1.25   
1.0%
0%
ENTAEnanta Pharmaceuticals   2.60   
3.0%
0%

Additional Tools for Catalent Stock Analysis

When running Catalent's price analysis, check to measure Catalent's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Catalent is operating at the current time. Most of Catalent's value examination focuses on studying past and present price action to predict the probability of Catalent's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Catalent's price. Additionally, you may evaluate how the addition of Catalent to your portfolios can decrease your overall portfolio volatility.